Back

Eli Lilly to Acquire Kelonia Therapeutics in Deal Worth Up to $7 Billion

The transaction includes a $3.25 billion upfront payment, while Eli Lilly shares were up 0.16% following the announcement.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Genetic medicine: A treatment approach that uses genes or genetic material to address disease at its source.
  • Upfront payment: An initial payment made at the time a deal is signed, with additional payments potentially tied to later milestones.